Quantcast

Latest bloating Stories

2011-11-21 12:26:30

A patient's viewpoint of the severity of irritable bowel syndrome (IBS) symptoms can be influenced not only by physical symptoms of IBS but broader psychological problems, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association. "Clinicians who face pressure to treat patients in a cost-effective manner within tight time constraints and at a satisfactory level are likely to find that patient-reported outcome...

2011-11-02 09:10:45

Among the most commonly used treatments for IBS, a targeted antibiotic was shown to be the safest in a new study by Cedars-Sinai researchers Among the most commonly used treatments for irritable bowel syndrome — which affects as many as 20 percent of the United States population — a targeted antibiotic was shown to be the safest in a new study by Cedars-Sinai researchers, based on an analysis of 26 large-scale clinical trials. The study, for presentation at the American...

2011-06-16 07:00:00

SAN DIEGO, June 16, 2011 /PRNewswire/ -- Tioga Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office (USPTO) has issued Patent No.7,960,429 "KAPPA-OPIATE AGONISTS FOR THE TREATMENT OF DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME." This patent covers the use of asimadoline to treat diarrhea predominant irritable bowel syndrome (D-IBS) and has an expiration date in June, 2028. The recently issued patent is owned by Tioga Pharmaceuticals. A continuation...

2011-06-01 07:00:00

SAN DIEGO, June 1, 2011 /PRNewswire/ -- Tioga Pharmaceuticals, Inc. announced today that its investigational compound asimadoline has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of patients with diarrhea-predominant irritable bowel syndrome (D-IBS). Tioga is conducting a multi-center Phase 3 clinical trial evaluating asimadoline in D-IBS, conducted under a Special Protocol Assessment agreement with the FDA for U.S. registration. The...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.